@OUHealth Stephenson Cancer Center is Oklahoma's only National Cancer Institute-Designated Cancer Center.
Oklahoma City, OK
Joined November 2011
- Tweets1.6K
- Following293
- Followers1.6K
- Likes1.7K
OU Health Stephenson Cancer Center retweeted
Back in action in Salt Lake City to enter the post All-Star stretch of the season 📍
@NickAGallo and @ParisNLawson prep you for the game in today’s @OUHealth Game Day Report 📝
OU Health Stephenson Cancer Center retweeted
New #OUResearch is pioneering a new blood test that could revolutionize early detection for cancer.
Partnering with @GrailBio, researchers at the @StephensonCC are studying a test that may identify over 50 types of cancer before they spread.
Learn more: link.ou.edu/4dFqLDW
OU Health Stephenson Cancer Center retweeted
Dr. Motolani (Ogunsanya) Adedipe, an OU researcher from the @StephensonCC, has received a $1.3M grant from the @DeptofDefense to test a new mobile app designed to address health disparities among Black men with prostate cancer.
Read more: link.ou.edu/3V10wPT
OU Health Stephenson Cancer Center retweeted
“In the United States, Black men are …diagnosed with prostate cancer at a 60% higher rate than white men…” @StephensonCC researcher, Dr. Motolani (Ogunsaya) Adedipe, is working to address these disparities with a new app with a @DeptofDefense grant.
#LeadOn Dr. Adedipe!
Dr. Motolani (Ogunsanya) Adedipe, an OU researcher from the @StephensonCC, has received a $1.3M grant from the @DeptofDefense to test a new mobile app designed to address health disparities among Black men with prostate cancer.
Read more: link.ou.edu/3V10wPT
OU Health Stephenson Cancer Center retweeted
Journey Ends for Upifitamab Rilsodotin in NaPi2b+ Platinum-Resistant Ovarian Cancer @debbieric23 @StephensonCC @oucollegeofmed @OUHealth @sgo_org #SGOMtg #gyncsm
onclive.com/view/journey-end…
OU Health Stephenson Cancer Center retweeted
Want to hear more about the UPLIFT trial and the evaluation of upifitamab rilsodotin in #OvarianCancer? Check back to OncLive.com to hear more from Dr Richardson, of @StephensonCC, on the topic: onclive.com/view/dr-richards…
OU Health Stephenson Cancer Center retweeted
Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer. @debbieric23 @StephensonCC @oucollegeofmed @OUHealth @sgo_org #SGOMtg #gyncsm onclive.com/view/journey-end…
OU Health Stephenson Cancer Center retweeted
Every cancer journey is unique, and not all therapies lead to success.
Thanks to Abdul Rafeh Naqash, M.D. from @StephensonCC, breakthroughs are happening with his research meaning more patients could receive personalized care tailored to their needs.
🔗 link.ou.edu/3x6IH9O
OU Health Stephenson Cancer Center retweeted
Groundbreaking #OUResearch from @StephensonCC delves into the intricate role of vitamin B6 in pancreatic cancer.
@OUCollegeofMed's Dr. Kamiya Mehla aims to boost the body's immune system against cancer's relentless pursuit of this essential vitamin.
🔗 link.ou.edu/4bUXKmJ
OU Health Stephenson Cancer Center retweeted
Congratulations to OU Health Stephenson Cancer Center in OKC for your selection by the National Institutes of Health to provide research on emerging cancer screenings to help with early detection.
OU Health Stephenson Cancer Center retweeted
TSET partners with 3 incredible research programs: the @StephensonCC, the Health Promotion Research Center and the Oklahoma Center for Adult Stem Cell Research. Learn more about each of them here: bit.ly/48XBoz9
ALT Image of a woman in a lab.
OU Health Stephenson Cancer Center retweeted
.@StephensonCC is proud to join @theNCI's Cancer Screening Research Network.
Together, we're exploring groundbreaking research, funded by the @NIH, to enhance cancer screening for Oklahomans facing higher cancer risk and limited access.
Learn more: link.ou.edu/3OQlDCj
OU Health Stephenson Cancer Center retweeted
OU Health Sciences and @StephensonCC have launched the Scientific Training in Oncology (STRONG) program!
This initiative, made possible by @AmericanCancer, aims to provide unique career opportunities while fostering diversity in cancer research.
🔗 link.ou.edu/3SqBFnf
OU Health Stephenson Cancer Center retweeted
#OUResearch in the News: Groundbreaking research from OU Health Sciences could save countless lives.
Featured on @kfor, OU researchers from the @StephensonCC discuss a first-of-its-kind study aimed at revolutionizing the detection of pancreatic cancer.
kfor.com/news/local/oklahoma…
OU Health Stephenson Cancer Center retweeted
Preclinical Study Reveals Potential Role for GLP-Agonists in Endometrial Cancer @DKrauseMD @StephensonCC #gyncsm #oncology #MedTwitter
onclive.com/view/preclinical…
OU Health Stephenson Cancer Center retweeted
Researchers at @StephensonCC have embarked on a revolutionary new research study that could improve the detection of pancreatic cancer and give patients a chance to live longer, healthier lives.
Learn more: link.ou.edu/3vWf22A
OU Health Stephenson Cancer Center retweeted
#OUResearch in the news: Dr. Kathleen Moore from @StephensonCC is spearheading a global trial for ovarian cancer treatment, marking a significant step toward potential life-saving solutions.
Dr. Moore's groundbreaking research is featured on @KTULNews.
ktul.com/news/local/ou-resea…
OU Health Stephenson Cancer Center retweeted
The addition of GLP-1 receptor agonist therapy to progesterone did not negatively impact the therapeutic effect of progesterone in an obesity-associated mouse model of endometrial cancer. @DKrauseMD @StephensonCC #gyncsm #oncology #MedTwitter onclive.com/view/preclinical…
OU Health Stephenson Cancer Center retweeted
Five years ago this month, @stephensonCC @OUHealth treated their 1st patient on the MEVION S250i. 🎉 We extend our warmest congratulations to everyone involved in this incredible achievement!
#ProtonTherapy #IMPT #MedPhys #RadOnc #CancerTreatment #Mevion
OU Health Stephenson Cancer Center retweeted
Kathleen Moore, M.D., associate director of clinical research at @StephensonCC and a professor at the @OUCollegeofMed, is leading a global trial on a new drug that aims to significantly improve survival in women with epithelial ovarian cancer.
Read more: link.ou.edu/47JhWoD
